Abstract: HIV-infected patients exhibit quantitative and qualitative defects in CD4 T cells, including having increased numbers of CD4+CD45R0+/CD45RA+ T cells, although it remains unclear how these cells arise. Here we demonstrate that gp120 treatment of activated but not resting primary human CD4 T cells decreases number of cells with single positive CD45R0+/CD45RA-effector memory phenotype while proportionally increasing the subset of cells with double positive CD45R0+/CD45RA+ mixed phenotype. We found that double positive CD45R0+/CD45RA+CD4 T cells preferentially undergo apoptosis while single positive CD45R0+/CD45RA-and CD45R0-/CD45RA+ do not. Blocking gp120-CD4 interaction with sCD4 or inhibition Lck activity reverses gp120 induced increase in double positive CD45R0+/CD45RA+CD4 T cells and subsequently diminishes the apoptosis of double positive CD45R0+/CD45RA+ cells. Altogether these data indicate that gp120 ligation of the CD4 receptor increases the number of double positive CD45R0+/CD45RA+ CD4 T cells which subsequently undergo apoptosis in a CD4 dependent manner.
INTRODUCTION
One hallmark of HIV pathogenesis is a decline of CD4 T cell number that results from the death of both HIV-1 infected CD4 T cells, as well as uninfected cells. Both HIV expressed proteins, as well as immune activation, contribute to this T cell death [1] . Immune activation leads to an increase in T cell turnover from enhanced proliferation which in turn is associated with high rates of apoptosis [2, 3] . The magnitude of immune activation correlates with the level of HIV viremia [4] . Increased expression of immune activation markers (HLA-DR+, CD38+, CD45RO+, and CD95) also correlates with higher apoptosis rates of CD4 T cells [5] . Importantly, suppression of viral replication with HAART treatment reduces immune activation [6, 7] , normalizes expression of activation markers, and decreases CD4 T cell apoptosis [8] [9] [10] .
As a result of chronic immune activation, central memory and naïve CD4 T cells are constantly recruited into the effector pool [11, 12] resulting in dramatic changes in populations of naïve, effector and central memory CD4 T cells [13] . The mechanisms of how the ratio of these CD4 T cells is altered during HIV infection are not completely understood.
In particular, chronic HIV infection results in an increased number of CD4 T cells with a peculiar double positive CD45RO+/CD45RA+/CD25+CD4+ phenotype, and this subset is further increased following intermittent IL-2 therapy [14] . The origin of this subset was previously ascribed to be transition phase of naïve CD45RO-/CD45RA+CD4 T cells transitioning to a memory CD45RO+/CD45RA-CD4 T cell phenotype [15] . Furthermore, HAART with IL-2 therapy selectively increases the number of activated CD4 T cell expressing CD45RO+/CD25+ [16] . Here we describe a *Address correspondence to this author at the Division of Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; Tel: 507-266-5065; Fax: 507-284-3757; E-mail: badley.andrew@mayo.edu novel effect of HIV-1 gp120 signaling through CD4 resulting in altered CD45 isoform expression by CD4 T cells.
MATERIALS AND METHODOLOGY

Cell Culture and Reagents
This protocol was reviewed and approved by the Mayo institutional review board. CD4+ T cells were isolated from the blood of healthy volunteer blood donors by using RossetteSep CD4 enrichment cocktail (StemCell Technologies, Vancouver, British Columbia, Canada), producing 98% pure CD4+ T cells as determined by flow cytometry. CD4 T cells were maintained in RPMI 1640 supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad, CA), 2 mM Lglutamine, and antibiotics (penicillin 100 U/ml, streptomycin 100 μg/ml) at 0.5x10 6 cells/ml. CD4+ T cells used in the various experiments were stimulated with PHA (1 μg/ml) for 24 hours, and then cells were washed twice with RPMI 1640 and maintained in media supplemented with 50 U/ml of IL-2 for 48-72 hours. CD4 T cells were incubated with HIV-1 X4 gp120IIIB (Immuno Diagnostics, Inc. Woburn, MA) or gp120 IIIB pretreated with soluble CD4 (1:2 ratio) (Immuno Diagnostics, Inc. Woburn, MA) at concentrations of 1 μg/ml/2x10 6 cells for 24 hours at 37°C. AMD3100 (NIH AIDS Research and Reference program) was used at 2 μM for 30 minutes at 37°C. PP2 was purchased from CalBiochem (La Jolla, CA). Anti-CD4-PE, anti-CD25-FITC, anti-CD69-PE, anti-CD4PerCP, anti-CD62L-PE, anti-CD45RO-FITC, anti-CD45RA-PE-Cy-7, anti-HLA-DR-PE, AnnexinV-Cy-5, AnnexinV-APC, IgG1 -PE-Cy7, IgG2a-FITC, IgG1 -PE and propidium iodine were purchased from BD Biosciences (San Jose, CA).
Cell Death Analysis and Flow Cytometry
CD4 T cells were untreated or pre-incubated with specific inhibitors and stimulated with either BSA or with soluble gp120IIIB (10μg/ml) overnight. The following day, cell death was analyzed by staining with AnnexinV-Cy-5 and propidium iodine following the manufacturer's instructions from BD Biosciences (San Jose, CA). All experiments were performed at least three times.
T cell phenotyping studies were performed by using fourcolor Flow analysis on FACSCanto cytometer and using FACSDiva 6.0 software. Briefly, 2x10 6 cells were resuspended in 200μl of PBS+0.5%BSA, stained with the indicated primary conjugated antibodies for 20 minutes (anti-CD45RO-FITC, anti-CD45RA-PE-Cy-7, anti-CD27 APC and anti-CD62L-PE), washed, fixed and then analyzed. In some cases, for analysis of cell death, cells were stained in binding buffer (140 mM NaCl, 10 mM HEPES/NaOH (pH 7.4), 2.5 mM CaCl2) as described above except that anti-CD62L-PE was substituted with AnnexinV-PE.
RESULTS
Gp120 Decreases CD45RO+ Memory Phenotype in Activated But Not Resting CD4 T cells
We and others have previously demonstrated that gp120 induces death of resting CD4 T cell in a CXCR4-p38 dependent manner [17] . However, the effect of gp120 on activated CD4 T cells is largely unknown. To examine the effect of gp120, resting (CD4+CD25-CD69-HLA-DR-) and activated (CD4+ CD25+CD69+HLA-DR+) primary human CD4 T cells were treated with gp120 IIIB (10μg/ml) for 24 hours and then CD4 T cells were analyzed for CD45R0 and CD45RA expression by flow cytometry. As shown in Fig.  (1A) , gp120 treatment results in a 50% decrease in the subset of single positive CD45R0+/CD45RA-(31.85 + 0.63% with BSA, 13.80 + 3.73% with gp120, p=0.01) memory cells when activated but not resting CD4 T cells are treated with gp120 (34.25 + 1.1% with BSA, 28.95 + 1.96% with gp120, p=0.08). In parallel, there is a proportional increase in the subset of double positive CD45R0+/CD45RA+ mixed phenotype CD4+ T cells (Fig. 1B) as well as an increase in the proportion of Annexin-V positive CD4 T cells (Fig. 1C) . While the increased apoptosis of resting cells following gp120 is due to CXCR4 signaling [17] , the mechanisms by which gp120 causes death in activated cells are unknown.
The finding that gp120 treatment of activated cells increases the lymphoid homing marker, CD27 (13.8% of total CD4 T cells) preferentially in double positive CD45R0+/CD45RA+ cells suggests that these cells might be the specific cell type which dies following gp120 treatment of activated CD4 T cells (Fig. 2A, B) . We therefore measured absolute number and proportion of Annexin-V positivity of double positive CD45R0+/CD45RA+, single positive CD45R0-/CD45RA+ and CD45R0+/CD45RA-subsets by using four color flow cytometry analysis. First we observed that CD45RO+RA-proportion decreased (39.42 + 3.44% with BSA, 27.31 + 6.38% with gp120) while CD45RO+RA+ population increased (35.97 + 2.70% with BSA, 49.42 + 10.05% with gp120), suggesting that the former transitioned to the latter (Fig. 3A) . Next we observed that only double positive CD45R0+/CD45RA+ CD4 T cell subset contain a significant proportion of Annexin positive cells (~40%) in contrast to single positive CD45R0+/CD45RA-and CD45R0-/CD45RA+ subsets that do not (Fig. 3B) . Therefore, gp120 signaling both activates cells towards a double positive phenotype and subsequently promotes their apoptotic death. Of interest, these Annexin positive CD45R0+/CD45 RA+ cells are also CD27+. Altogether these results indicate that gp120 treatment of activated CD4 T cells result in decrease memory CD45R0+/CD45RA-CD4 T cells due to accumulation of CD45R0+/CD45RA+ /CD27+ T cell subset that subsequently and selectively undergo apoptosis. 
Gp120 Stimulated Accumulation of CD45RO+/CD45 RA+ CD4 T Cells Requires CD4 and Lck But Not CXCR4
To investigate whether gp120 effect on CD45R0+/CD45RA+ CD4 T cell is due to ligation to CD4 or CXCR4, we used either soluble CD4 or the CXCR4 inhibitor, AMD3100. Independent experiments verified the activity of AMD3100 by blocking SDF-induced chemotaxis (data not shown). As shown in Fig. (4A, B) , inhibition of CD4 ligation by sCD4 [17] blocks the increase in double positive CD45R0+/CD45RA+ memory cells. Consistent with this observation, inhibition of Lck activity with PP2 inhibitor also blocks increase in CD45R0+/CD45RA+ CD4 T cell subset. Conversely inhibition of gp120-CXCR4 interaction with AMD3100 [17] does not block completely gp120 mediated increase of CD45R0+/CD45RA+ CD4 T cells. Therefore, our results demonstrate that gp120 ligation to CD4 and subsequent activation of Lck results in accumulation of double positive CD45R0+/CD45RA+ memory CD4 T cells which subsequently and selectively undergo apoptosis in a CD4 dependent and CXCR4 independent manner.
DISCUSSION
In the current report we have shown that gp120 treatment of activated CD4 T cells decreases the subset of single positive CD45R0+/CD45RA-CD4 T cells and increases the subset of double positive CD45R0+/CD45RA+ CD4 T cells which selectively undergo apoptosis. These results imply the gp120 may play a role in depletion of memory CD45R0+/ CD45RA-CD4 T during HIV.
Previously, the CD45R0+/CD45RA+ subset of CD4 T cells was characterized as a transition from naïve to effector phenotype during CD4 priming [15, 18] with increased expression of activation markers [19, 20] . The generation of this subset can occur in two ways: (i) the transition of recently activated of CD45RA+ T naïve cells to CD45R0+/ CD45RA+ phenotype [15, 21] and; (ii) re-expression of CD45RA isoform in the absence of Ag stimulation [15] . The fact that only few CD45R0+/CD45RA+ cells express markers of recently activated cells [19, 20] and upregulation of CD45RA+ (up to 10%) by CD45RO+/CD45RA-cells [15] suggest that gp120 rather upregulates CD45RA+ on single positive CD45RO+/CD45RA-memory CD4 T cells rather than promoting CD45RO expression on naïve CD4 T cells. Indeed, increase of double positive CD45RO+/CD45 RA+ CD4 T cells is followed by proportional decrease in CD45RO+/CD45RA-memory but not decrease in naïve CD45RO-/CD45RA+ CD4 T cells.
Others have shown that PBMC stimulated with staphylococcal enterotoxin A (SEA) in the presence of V3-derived gp120 peptides results in increase of CCR5+/CXCR4+/ CD45RO+ CD4 T cells followed by increased levels of apoptosis [22] . Our findings are in good agreement with this observation: first, both results demonstrate the gp120 mediated increase in transient state from naïve to activated CD4 T cells; second, both studies observe the increased apoptosis of activated CD4 T cells in the presence of gp120 or V3-derived peptide. However, our results highlight that gp120 priming of previously activated CD4 T cells reverses single positive CD45RO+/CD45RA-effector phenotype to double positive CD45RO+ /CD45RA+ transient phenotype.
The observation that double positive CD45R0+/CD45 RA+ preferentially undergo apoptosis presents one potential scenario of how inappropriately activated CD4 T cells die during HIV disease, and why IL-2 augments this process [16] . It is of further interest that gp120 treatment results in apoptosis of CD27+/CD45R0+/CD45RA+ cells. In fact, CD27 expression is rapidly upregulated following TCR stimulation [23] and CD27 signaling is essential for survival of Ag-primed CD4 T cells [24] . Therefore, either the lack of antigen specific signaling or the lack of CD27 signaling may explain the increased apoptosis of double positive CD45R0+/CD45RA+ following gp120 treatment. Finally, the observation that CD4 ligation by gp120 and subsequent activation of Lck is required for generation of double positive CD45R0+/CD45RA+ CD4 T cells is of relevance and suggests that inhibitors of CD4-gp120 interactions may reverse the expansion of double positive CD45R0+/CD45RA+ population and subsequent increased apoptosis during HIV infection. The data represents three independent experiments as described above. P values were determined by Student's paired t test. *=P<0.05 compared to gp120 alone. 
